Volume increase in L5222 leukemic cells following chemotherapy: manifestation of leukemic cell damage.
D000818:Animals; D001202:Ascitic Fluid / Q000473:pathology; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006918:Hydroxyurea / Q000627:therapeutic use; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000473:pathology*; D051381:Rats; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D005472:Fluorouracil; D006918:Hydroxyurea; D003630:Daunorubicin